Medipharm Labs Corp (LABS) — Long-term Investment Intensity
Medipharm Labs Corp (LABS) has a Long-term Investment Intensity of 0.2% as of September 2021. Long-term investments of CA$191.00K represent 0.2% of total assets of CA$118.20 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check LABS cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Medipharm Labs Corp Long-term Investment Intensity (2017–2020)
This chart shows how Medipharm Labs Corp's Long-term Investment Intensity has evolved across 4 annual periods from 2017 to 2020. As of September 2021, the intensity stands at 0.2%, reflecting long-term investments of CA$191.00K against total assets of CA$118.20 Million CAD. Explore LABS debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Medipharm Labs Corp (2017–2020)
The table below presents the year-by-year Long-term Investment Intensity for Medipharm Labs Corp from 2017 to 2020, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see LABS stock market capitalisation.
| Year | LT Investment Intensity | LT Investments (CAD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2020 | 0.2% | CA$191.00K | CA$118.23 Million | ▲ +0.0 pp |
| 2019 | 0.1% | CA$189.00K | CA$168.83 Million | ▼ -0.1 pp |
| 2018 | 0.2% | CA$81.00K | CA$42.73 Million | ▼ -12.3 pp |
| 2017 | 12.5% | CA$50.00K | CA$400.00K | — |